Description: Measurement of globotriaosylceramide in the urine by LC-MSMS.

Test Indications: This test is used to monitor patients with Fabry disease.
This test can be helpful following the identification of a variant of unknown significance.

Test Approval Requirements: F260-11-02 Biochemistry Approval for Test Referral Form
 

Fill out CHUS (Sherbrooke University) Biochemical Genetics Requisition, Attach to Biochemistry Requisition.

 Link to requisition: CHUS Requisition

Required Fields:

Requestor Identification

                Requesting MD:

Patient Identification

                Surname:

                First name:

                Gender:

                Date of birth:

                RAMQ# (PHIN):

Biochemical Genetic Tests:

                Gb3 (globotriaosylceramide) - GLOTG